PortfoliosLab logo

CTI BioPharma Corp. (CTIC)

Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US12648L6011
CUSIP
12648L601

CTICPrice Chart


Chart placeholderClick Calculate to get results

CTICPerformance

The chart shows the growth of $10,000 invested in CTI BioPharma Corp. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $62 for a total return of roughly -99.38%. All prices are adjusted for splits and dividends.


CTIC (CTI BioPharma Corp.)
Benchmark (S&P 500)

CTICReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-9.27%-1.87%
1M22.28%-0.21%
6M-6.25%8.24%
1Y-36.26%24.78%
5Y-14.06%15.48%
10Y-27.45%13.85%

CTICMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

CTICSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current CTI BioPharma Corp. Sharpe ratio is -0.54. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


CTIC (CTI BioPharma Corp.)
Benchmark (S&P 500)

CTICDividends


CTI BioPharma Corp. doesn't pay dividends

CTICDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CTIC (CTI BioPharma Corp.)
Benchmark (S&P 500)

CTICWorst Drawdowns

The table below shows the maximum drawdowns of the CTI BioPharma Corp.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the CTI BioPharma Corp. is 99.84%, recorded on Aug 9, 2019. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.84%Jan 14, 20102409Aug 9, 2019
-2.5%Jan 5, 20106Jan 12, 20101Jan 13, 20107

CTICVolatility Chart

Current CTI BioPharma Corp. volatility is 34.53%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CTIC (CTI BioPharma Corp.)
Benchmark (S&P 500)

Portfolios with CTI BioPharma Corp.


Loading data...

More Tools for CTI BioPharma Corp.